小丈夫

Zhuque-3 chief commander reveals cause of Y1 rocket's failed recovery, saying its data contributed to Y2's success_我的网站

A |     华东医药：含利多卡因注射用交联透明质酸钠凝胶MaiLi Precise注册申请获得上市批准 每经AI快讯，华东医药（SZ000963，收盘价：27.28元）8月25日晚间发布公告称，2026年8月25日，华东医药股份有限公司全资子公司欣可丽美学（杭州）医疗科技有限公司收到国家药品监督管理局（NMPA）签发的《医疗器械注册证》，其代理申报的三类医疗器械含利多卡因注射用交联透明质酸钠凝胶MaiLiPrecise注册申请获得上市批准，是国内首款治疗眶下凹陷的注射产品。    

    ZQ-3 Y1 rocket took off for maiden flight from the Dongfeng Commercial Aerospace Innovation Test Zone at noon time on December 3, 2025. Photo: courtesy of LandSpaceThe cause of an unsatisfying recovery of the Zhuque-3 Y1 carrier rocket has recently been revealed by Zhuque-3's chief commander, who said an abnormal combustion occurred during a landing ignition as the rocket descended toward the ground, state broadcaster China Central Television (CCTV) News reported on Wednesday.
The recovery of the first stage of Zhuque-3, China's first reusable carrier rocket developed by LandSpace, was failed during a test flight back on December 3, 2025, while the second stage of the rocket managed to successfully enter the designated orbit, according to the Xinhua News Agency.
Dai Zheng, chief commander of Zhuque-3, said that when the rocket was about 3.3 kilometers above the ground, it needs to perform a rapid deceleration maneuver by reigniting its engine, a process known as a "landing ignition."
"The ignition sequence was completed and the engine did ignite, but abnormal combustion occurred afterward. The rocket eventually crashed near the edge of the landing pad," Dai said, according to CCTV.
Although the rocket did not achieve a successful recovery, the mission, China's first orbital-class rocket first-stage recovery test, collected telemetry data during the return phase, provided a clearer picture of the flight environment throughout the recovery process, and yielded a large amount of valuable first-hand test data, per CCTV. 
Drawing on the data collected from the Zhuque-3 Y1 mission, the development team made improvements to the Y2 launch vehicle.
Eight months after the Y1's unsatisfying recovery, the Zhuque-3 Y2 reusable launch vehicle on Wednesday conducted a flight test, carrying not only a satellite payload but also successfully carried out a major test of China's emerging reusable rocket capabilities. After completing its orbital mission, the rocket's first stage attempted a controlled return and recovery.
The Y2 mission was conducted on the basis of experience accumulated from the previous flight test, with improvements focused on recovery reliability, flight control and engine performance.
LandSpace said it optimized the first-stage landing propulsion scheme by reducing the number of engines used during landing ignition, simplifying system design and improving reliability during the recovery phase. The company also added an autonomous safety control function capable of predicting landing points based on flight conditions and making corresponding safety adjustments.  
Global Times 
。产品名称为“含利多卡因注射用交联透明质酸钠凝胶”。    每经头条（nbdtoutiao）——冲刺“全球视频大模型第一股”！每经独家透视可灵AI：客户都在哪？运营状况如何？     （记者陈鹏程）     免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。    每日经济新闻     。

Current article:http://www.minpinpengcemiuanjiuxuan.pics/o7xf2/1cvhh0w.doc

Published on:20:08:09